Treatment of peripheral arterial disease using stem and progenitor cell therapy.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Vascular Surgery

• Publication date

  2011-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jvs.2010.08.060PMID 21030198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature.

  2010cited by this paper
• Stem cell and progenitor cell therapy in peripheral artery disease

  2010cited by this paper
• Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study

  2009cited by this paper
• Autologous Bone Marrow Cell Transplantation Increases Leg Perfusion and Reduces Amputations in Patients with Advanced Critical Limb Ischemia Due to Peripheral Artery Disease

  2009cited by this paper
• Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot.

  2009cited by this paper
• Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.

  2008cited by this paper
• Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.

  2008cited by this paper
• Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).

  2008cited by this paper
• Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction.

  2007cited by this paper
• Aging in the Atherosclerosis Milieu May Accelerate the Consumption of Bone Marrow Endothelial Progenitor Cells

  2007cited by this paper
• Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans

  2007cited by this paper
• Endothelial progenitor cells in the natural history of atherosclerosis.

  2007cited by this paper
• Good Manufacturing Practice-Compliant Expansion of Marrow-Derived Stem and Progenitor Cells for Cell Therapy

  2007cited by this paper
• Peripheral endothelial progenitor cells (CD133 +) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up.

  2007cited by this paper
• Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

  2006cited by this paper
• Regulation of angiogenesis by hypoxia-inducible factor 1.

  2006cited by this paper
• Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial.

  2006cited by this paper
• ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography

  2006cited by this paper
• Unblinded Pilot Study of Autologous Transplantation of Bone Marrow Mononuclear Cells in Patients With Thromboangiitis Obliterans

  2006cited by this paper
• Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

  2006cited by this paper
• Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

  2006cited by this paper
• Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

  2005cited by this paper
• START Trial: A Pilot Study on STimulation of ARTeriogenesis Using Subcutaneous Application of Granulocyte-Macrophage Colony-Stimulating Factor as a New Treatment for Peripheral Vascular Disease

  2005cited by this paper
• Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia.

  2005cited by this paper
• Granulocyte-colony stimulating factor augments neovascularization induced by bone marrow transplantation in rat hindlimb ischemia.

  2005cited by this paper
• CD14+CD34low Cells With Stem Cell Phenotypic and Functional Features Are the Major Source of Circulating Endothelial Progenitors

  2005cited by this paper
• Autologous skeletal myoblasts transduced with a new adenoviral bicistronic vector for treatment of hind limb ischemia.

  2004cited by this paper
• Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

  2004cited by this paper
• Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms

  2004cited by this paper
• Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers

  2004cited by this paper
• Endothelial Progenitor Cells: Characterization and Role in Vascular Biology

  2004cited by this paper
• Endothelial Progenitor Cells: Characterization and Role in Vascular Biology Bone Marrow–Derived Cells for Enhancing Collateral Development: Mechanisms, Animal Data, and Initial Clinical Experiences Arteriogenesis Innate Immunity and Angiogenesis Syndecans Growth Factors and Blood Vessels: Differenti

  2004cited by this paper
• Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells.

  2004cited by this paper
• A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware.

  2004cited by this paper
• Bone marrow-Derived Cells Do Not Incorporate Into the Adult Growing Vasculature

  2004cited by this paper
• OXIDIZED LOW‐DENSITY LIPOPROTEIN INDUCES ENDOTHELIAL PROGENITOR CELL SENESCENCE, LEADING TO CELLULAR DYSFUNCTION

  2004cited by this paper
• Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

  2004cited by this paper
• Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia.

  2003cited by this paper
• Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors

  2003cited by this paper
• Collateral Growth: Cells Arrive at the Construction Site

  2002cited by this paper
• A CRITICAL APPRAISAL

  2002cited by this paper
• Separation of Human Lymphocytes from Citrated Blood by Density Gradient (NycoPrep) Centrifugation: Monocyte Depletion Depending upon Activation of Membrane Potassium Channels

  2002cited by this paper
• Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

  2002cited by this paper
• Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans

  2002cited by this paper
• Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease

  2001cited by this paper
• Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease.

  2001cited by this paper
• [Angiogenesis and arteriogenesis; the long road from concept to clinical application].

  2001cited by this paper
• Peripheral arterial disease detection, awareness, and treatment in primary care.

  2001cited by this paper
• Thromboangiitis obliterans (Buerger's disease).

  2000cited by this paper
• Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

  2000cited by this paper
• The pathophysiology of the collateral circulation (arteriogenesis)

  2000cited by this paper
• Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

  1999cited by this paper
• Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

  1999cited by this paper
• Prevalence of Coexistence of Coronary Artery Disease, Ischemic Stroke, and Peripheral Arterial Disease in Older Persons, Mean Age 80 Years, in an Academic Hospital‐Based Geriatrics Practice

  1999cited by this paper
• Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

  1999cited by this paper
• Thromboangiitis Obliterans (Buerger's Disease)

  1997cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Separation of Leucocytes: Improved Cell Purity by Fine Adjustments of Gradient Medium Density and Osmolality

  1991cited by this paper
• Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media.

  1984cited by this paper
• Separation of lymphocytes, lymphocyte subgroups and monocytes: a review.

  1977cited by this paper
• One-year follow-up

  1975cited by this paper

• Clinical Trial Landscape of Stem Cell Therapy for Peripheral Arterial Disease

  2025cites this paper
• Treatment Options for Buerger Disease: A Systematic Review and Meta-Analysis of Outcomes.

  2025cites this paper
• Efficacy and safety of stem cell therapy in patients with chronic lower extremity ulcers: an umbrella review of systematic reviews and meta-analyses

  2025cites this paper
• Effectiveness of quality and quantity mononuclear cells for enhancing wound healing in diabetic ischemic limb animal model

  2025cites this paper
• Cutting-edge approaches to diagnosing and treating limb ischemia in peripheral arterial disease

  2025cites this paper
• Bioengineering Cell Therapy for Treatment of Peripheral Artery Disease.

  2024cites this paper
• The Systemic Effect of Ischemia Training and Its Impact on Bone Marrow-Derived Monocytes

  2024cites this paper
• Loss of c-Kit in Endothelial Cells Protects against Hindlimb Ischemia

  2024cites this paper
• miR-709 exerts an angiogenic effect through a FGF2 upregulation induced by a GSK3B downregulation

  2024cites this paper
• What Is the Best Experimental Model for Developing Novel Therapeutics in Peripheral Artery Disease?

  2024cites this paper
• Single cell transcriptomics identifies adipose tissue CD271+ progenitors for enhanced angiogenesis in limb ischemia

  2023cites this paper
• Single-cell transcriptomics identifies adipose tissue CD271+ progenitors for enhanced angiogenesis in limb ischemia

  2023cites this paper
• Wharton’s jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial

  2023cites this paper
• Knowledge Mapping of Global Status and Trends for Thromboangiitis Obliterans: A Bibliometrics and Visual Analysis

  2023cites this paper
• Top 100 cited articles in the thromboangiitis obliterans: a bibliometric analysis and visualized study

  2023cites this paper
• Animal experimental models of ischemic limbs - A systematic review.

  2023cites this paper
• The quality and quantity media-cultured mononuclear cell transplantation is safe and effective in ischemic hindlimb mouse model

  2023influential citation
• Stem Cell Therapy in Critical Limb Ischemia

  2023cites this paper
• Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)

  2023cites this paper
• Periosteal distraction for foot preservation contributes to favorable clinical effects and prognosis in a foot ulcer patient with critical limb ischemia after multiple operations.

  2023cites this paper
• Novel insights into the angiogenic function of JMJD2B in diabetic hind limb ischemia: involvement of activating Wnt/β-catenin pathway

  2023cites this paper
• Intravenous infusion of bone marrow-derived mesenchymal stem cells improves tissue perfusion in a rat hindlimb ischemia model

  2022cites this paper
• Effect of Revascularization on Intramuscular Vascular Endothelial Growth Factor Levels in Peripheral Arterial Disease

  2022cites this paper
• Radio-iodination and biological evaluation of pentoxifylline as a novel probe for diagnosis of intermittent claudication.

  2022cites this paper
• Comparison of Three Methods for Preparation of Autologous Cells for Use in Cell Therapy of Chronic Limb-Threatening Ischemia in People with Diabetes

  2022cites this paper
• The peripheral blood mononuclear cells versus purified CD34+ cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis—a randomized single-blinded non-inferiority trial

  2022cites this paper
• Dental Pulp Mesenchymal Stem Cells Attenuate Limb Ischemia via Promoting Capillary Proliferation and Collateral Development in a Preclinical Model

  2021cites this paper
• ROS-scavenging hybrid hydrogel for genetically engineered stem cell delivery and limb ischemia therapy

  2021cites this paper
• Angiogenic effects of cell therapy within a biomaterial scaffold in a rat hind limb ischemia model

  2021cites this paper
• Ischemic-Trained Monocytes Improve Arteriogenesis in a Mouse Model of Hindlimb Ischemia

  2021cites this paper
• Xenotransplantation of neonatal porcine bone marrow‐derived mesenchymal stem cells improves murine hind limb ischemia through lymphangiogenesis and angiogenesis

  2021cites this paper
• Notch signaling-modified mesenchymal stem cells improve tissue perfusion by induction of arteriogenesis in a rat hindlimb ischemia model

  2021cites this paper
• Cord Lining Mesenchymal Stem Cells Have a Modest Positive Effect on Angiogenesis in Hindlimb Ischemia

  2021cites this paper
• Novel culture media enhances mononuclear cells from patients with chronic limb-threatening ischemia to increase vasculogenesis and anti-in�ammatory effect

  2021cites this paper
• Novel culture media enhances mononuclear cells from patients with chronic limb-threatening ischemia to increase vasculogenesis and anti-inflammatory effect

  2021cites this paper
• Lymphangiogenesis and angiogenesis rescue murine ischemic hindlimb via transient receptor potential vanilloid 4.

  2021cites this paper
• Locoregional delivery of stem cell–based therapies

  2020cites this paper
• Local delivery of cardiac stem cells overexpressing HIF-1α promotes angiogenesis and muscular tissue repair in a hind limb ischemia model.

  2020cites this paper
• Injectable Therapeutic Organoids Using Sacrificial Hydrogels

  2020cites this paper
• Collateral Development and Arteriogenesis in Hindlimbs of Swine After Ligation of Arterial Inflow.

  2020cites this paper
• Changing the Course of Peripheral Arterial Disease Using Adult Stem Progenitor Cells

  2020cites this paper
• Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience

  2020cites this paper
• Autologous Skeletal Myoblast/Mononuclear Bone Marrow Cell Transplantation

  2019cites this paper
• Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia

  2019cites this paper
• Contrast-Enhanced Ultrasound Perfusion Imaging in Peripheral Arterial Disease

  2019cites this paper
• Diabetes impairs the angiogenic capacity of human adipose-derived stem cells by reducing the CD271+ subpopulation in adipose tissue.

  2019cites this paper
• Enrichment of vascular endothelial growth factor secreting mesenchymal stromal cells enhances therapeutic angiogenesis in a mouse model of hind limb ischemia.

  2019cites this paper
• In Vivo Photoacoustic Tracking of Mesenchymal Stem Cell Viability.

  2019cites this paper
• The Role of Poly(ADP-Ribose) Polymerase-1 in Cutaneous Wound Healing

  2019cites this paper
• Stem Cell Smart Technology, where are we now and how far we have to go?

  2018cites this paper
• Peripheral Blood Mononuclear Cells Therapy for Treatment of Lower Limb Ischemia in Diabetic Patients: A Single-Center Experience.

  2018cites this paper
• Autologous Stem Cell Therapy in Critical Limb Ischemia: A Meta-Analysis of Randomized Controlled Trials

  2018cites this paper
• Nanoparticles for Detection and Treatment of Peripheral Arterial Disease.

  2018cites this paper
• Allogeneic Adipose Mesenchymal Stem Cell Therapy in a Desperate Case of Forearm and Hand Ischemia

  2018cites this paper
• Use of Marine Compounds to Treat Ischemic Diseases

  2018cites this paper
• Laser Surface Microstructuring of a Bio-Resorbable Polymer to Anchor Stem Cells, Control Adipocyte Morphology, and Promote Osteogenesis

  2018cites this paper
• Nanohybrids with Magnetic and Persistent Luminescence Properties for Cell Labeling, Tracking, In Vivo Real-Time Imaging, and Magnetic Vectorization.

  2018cites this paper
• Protein-engineered hydrogels enhance the survival of induced pluripotent stem cell-derived endothelial cells for treatment of peripheral arterial disease.

  2018cites this paper
• Collateral development and arteriogenesis in hindlimbs of domestic swine after ligation of arterial inflow

  2018cites this paper
• Supramolecular hydrogels encapsulating bioengineered mesenchymal stem cells for ischemic therapy

  2018cites this paper
• Human diabetic mesenchymal stem cells from peripheral arterial disease patients promote angiogenesis through unique secretome signatures

  2018cites this paper
• Autologous Cell Therapy for Cardiac and Peripheral Arterial Disease

  2018cites this paper
• Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential

  2018cites this paper
• In-Site Monocyte Implantation in Bone Grafting for Maxillary Atrophy Reconstruction: A Preliminary Observational Proof of Concept Study

  2018cites this paper
• Purified CD34+ cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial

  2018cites this paper
• Placenta-derived PLX-PAD mesenchymal-like stromal cells are efficacious in rescuing blood flow in hind limb ischemia mouse model by a dose- and site-dependent mechanism of action.

  2017cites this paper
• Stem Cell Therapies in Peripheral Vascular Diseases — Current Status

  2017cites this paper
• Investigation of Chitosan-based Hydrogels as a Cell Delivery Platform for Adipose-derived Stem/Stromal Cell Transplantation to Promote Angiogenesis in Ischemic Tissues

  2017cites this paper
• Fabrication of decellularized adipose tissue/alginate composite microspheres with pASCs encapsulation for tissue engineering

  2017cites this paper
• The Long-Term Care of Patients with Critical Limb Ischemia (CLI)

  2017cites this paper
• Therapeutic Angiogenesis for Severely Ischemic Limbs — from Bench to Bedside in Acute Vascular Care

  2017cites this paper
• Uso de células pluripotenciales en el tratamiento de la isquemia crítica

  2017cites this paper
• Therapeutic strategies for cell-based neovascularization in critical limb ischemia

  2017cites this paper
• Improving the therapeutic efficacy of mesenchymal stromal cells to restore perfusion in critical limb ischemia through pulsed focused ultrasound

  2017cites this paper
• Stem-cell Therapy for Peripheral Arterial Disease Policy # 00298

  2017cites this paper
• Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia

  2017cites this paper
• Avoidance of Total Knee Arthroplasty in Early Osteoarthritis of the Knee with Intra-Articular Implantation of Autologous Activated Peripheral Blood Stem Cells versus Hyaluronic Acid: A Randomized Controlled Trial with Differential Effects of Growth Factor Addition

  2017cites this paper
• Wounds Difficult to Heal: An Effective Treatment Strategy.

  2017cites this paper
• A Molecular and Clinical Review of Stem Cell Therapy in Critical Limb Ischemia

  2017cites this paper
• Promoting Limb Salvage through Multi-Disciplinary Care of the Diabetic Patient

  2017cites this paper
• Evaluation of a new model of hind limb ischemia in rabbits

  2017cites this paper
• Non-reconstructable peripheral vascular disease of the lower extremity in ten patients treated with adipose-derived stromal vascular fraction cells.

  2017cites this paper
• High Aldehyde Dehydrogenase Activity Identifies a Subset of Human Mesenchymal Stromal Cells with Vascular Regenerative Potential

  2017cites this paper
• Pleiotropic effects of survivin in vascular endothelial cells.

  2016cites this paper
• A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization.

  2016cites this paper
• Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model.

  2016cites this paper
• Local injection of bone marrow progenitor cells for the treatment of anal sphincter injury: in-vitro expanded versus minimally-manipulated cells

  2016cites this paper
• Buerger’s disease: providing integrated care

  2016cites this paper
• The expression profile of angiogenic genes in critical limb ischemia popliteal arteries.

  2016cites this paper
• Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene.

  2016cites this paper
• [The results of combined surgical treatment of thromboangiitis obliterans and critical lower limb ischemia using prolonged epidural analgesia and autohemotherapy with ozone].

  2016cites this paper
• Alginate microencapsulation of human mesenchymal stem cells as a strategy to enhance paracrine‐mediated vascular recovery after hindlimb ischaemia

  2016cites this paper
• Thromboangiitis Obliterans

  2016cites this paper
• Cyclophilin A modulates bone marrow-derived CD117(+) cells and enhances ischemia-induced angiogenesis via the SDF-1/CXCR4 axis.

  2016cites this paper
• Adipose mesenchymal stromal cell therapy in a desperate case of right-hand ischemia.

  2016cites this paper
• Mutually Supportive Mechanisms of Inflammation and Vascular Remodeling.

  2016cites this paper
• Better Blood Flow Delivered

  2016cites this paper
• Mesenchymal Stromal Cells in Cardiovascular Disease

  2016cites this paper
• Mesenchymal Stem Cells for Treatment of Peripheral Vascular Disease

  2016cites this paper
• Extracellular Matrix-Derived Hydrogels for the Induction of Arteriogenesis in Peripheral Artery Disease?*

  2016cites this paper